Aehr Test Systems (AEHR) Earnings Swing Puts Valuation Back In Focus

Why Aehr Test Systems Stock Is Back In Focus

Aehr Test Systems (AEHR) has swung from loss to profit in its latest quarterly report, which is drawing fresh attention to the stock after a sharp pullback in recent months.

The share price reaction has been harsh in the short term, with Aehr Test Systems down 52% over the past month and 53% over the last 90 days. However, the year-to-date share price return is 132% and the 1-year total shareholder return is 98%. This points to strong longer-term gains but fading recent momentum as investors reassess both growth potential and risk after the earnings jump and the appointment of AI and infrastructure veteran Vijay Rao to the board in late October 2026.

Scan beyond Aehr Test Systems and compare this surge in earnings and AI exposure with a curated set of 53 AI infrastructure stocks that shape the same theme.

Aehr Test Systems now pairs a sharp earnings swing with a sharply lower share price. The business looks stronger. The key question is whether the current valuation still does the story justice.

Most Popular Narrative: 60% Undervalued

Aehr Test Systems closed at $51.47, while the most followed valuation story pegs fair value at about $130. That gap puts the focus squarely on whether the AI and data center thesis can carry the business toward the kind of scale that narrative assumes.

Rising AI processor and data center demand is feeding into Aehr Test Systems' FOX wafer-level and Sonoma package-level platforms. These platforms are tied to large purchase orders, a record backlog of about US$100.6 million, and a fiscal 2027 revenue outlook of US$130 million to US$150 million that directly targets higher revenue and operating income.

See why 8 investors see Aehr Test Systems as 60% undervalued.

Result: Fair Value of $130 (UNDERVALUED)

Still, the story can break if a concentrated AI and data center customer base pulls back on spending, or if backlog conversion into revenue proves slower than expected.

Find out about the key risks to this Aehr Test Systems narrative.

Another View: Aehr Test Systems Looks Expensive On Sales

There is a sharp contrast between the $130 fair value story and what the market is already paying for Aehr Test Systems on revenue. The stock trades on a P/S of 33.6x, compared with 5.9x for the broader US Semiconductor group and a fair ratio of 5.1x that the market could move toward over time.

Those gaps point to meaningful valuation risk if sentiment cools or revenue expectations reset, rather than an obvious margin of safety for new buyers.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

The mix of excitement and caution around Aehr Test Systems is clear, and the clock is always ticking when sentiment moves this fast. Put the numbers in context for your own situation by weighing the 1 key reward and 2 important warning signs.

Looking For More Investment Ideas Beyond Aehr Test Systems?

If Aehr Test Systems has your attention, do not stop there. Broader opportunities across sectors often come from ideas you did not initially expect to find.

• Target potential mispricing by scanning a curated set of 34 high quality undervalued stocks that pair solid fundamentals with market skepticism.
• Strengthen portfolio resilience by reviewing a list of solid balance sheet and fundamentals (24 results) that can help anchor returns during tougher conditions.
• Get ahead of the crowd by hunting through 19 high quality undiscovered gems that most investors have not fully researched yet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com